Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference
Co-Diagnostics, Inc. (Nasdaq: CODX) announced that key executives will participate in the Sidoti Summer Small Cap Virtual Investor Conference on June 15-16, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Co-Diagnostics, Inc. (Nasdaq: CODX) announced that key executives will participate in the Sidoti Summer Small Cap Virtual Investor Conference on June 15-16, 2022. CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson will present and hold one-on-one meetings with investors. The presentation starts at 3:15 p.m. EDT on June 15 and can be accessed via the company's website. Co-Diagnostics specializes in molecular diagnostics, focusing on developing tests that analyze nucleic acid molecules for various applications, including infectious diseases.
Details
News Market Reaction – CODX
The recorded move for CODX in the trading session of this news was +3.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, June 15, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Summer Small Cap Virtual Investor Conference June 15-16, 2022.
The presentation will begin at 3:15 p.m. EDT on Wednesday June 15, 2022, and can be accessed on the Events and Webcasts section of the Co-Diagnostics website. To register for the presentation or one-on-ones, please visit www.sidoti.com/events.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-sidoti-summer-small-cap-virtual-conference-301568436.html
SOURCE Co-Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.